Compare · head to head
PharmGen Science vs Pulmuone Corporate
PharmGen Science ranks higher overall — 360 rank 74 vs 50.
PharmGen Science leads on Value (57 vs 50) and Safety (73 vs 24). Pulmuone Corporate leads on Sentiment (60 vs 41). The two are close on Quality.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | South Korea |
| Sector | Health Care | Food, Drinks & Tobacco |
| Industry | Pharmaceuticals | Food Products |
| Size | Small | Medium |
| ISIN | KR7004720009 | KR7017810003 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 74 | 50 |
| Value | 57 | 50 |
| Quality | 54 | 53 |
| Growth | NR | 62 |
| Safety | 73 | 24 |
| Sentiment | 41 | 60 |
| Quality details | ||
| Profitability | 70 | 43 |
| Cash Truth | 38 | 63 |
PharmGen Science vs Kukje PharmaPharmGen Science vs Reyon PharmaceuticalPharmGen Science vs Green ChemicalPharmGen Science vs Samil PharmaceuticalAdd a third stock →
Full analyses: PharmGen Science · Pulmuone Corporate
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100